Wolfgang Miesbach: How Haemophilia Care Has Evolved in China
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn about a recent article by Yun Wang et al, published in RPTH Journal, adding։
”Same disease – different realities.
Just read a very insightful review by Xue, Poon, Yang and colleagues on how haemophilia care has evolved in China, and it really challenges the usual Euro‑/US‑centric perspective:
The authors describe how China has compressed decades of progress into a short time frame: building a nationwide tiered center network, scaling up domestic plasma‑derived and recombinant factors, introducing new non‑factor therapies, and pushing ahead with multiple AAV gene therapy programs – all while still grappling with underdiagnosis, marked urban–rural disparities, and substantial out‑of‑pocket burden for many patients.
What I find especially interesting is that China is not just copying Western models; strong national policy, local manufacturing, and home‑grown innovation (from rFVIIa and FX activators to anti‑TFPI and anti–protein C antibodies) are turning it into a rapidly emerging source of real‑world data, new drugs, and alternative care structures that could influence haemophilia management well beyond China.”
Title: The therapeutic landscape of inherited bleeding disorders in China
Authors: Yun Wang, Feng Xue, Man-Chiu Poon, Renchi Yang
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives